These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. Liu C; Tsao MS Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369 [TBL] [Abstract][Full Text] [Related]
5. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer. Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868 [TBL] [Abstract][Full Text] [Related]
6. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas. Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059 [TBL] [Abstract][Full Text] [Related]
8. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study. Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203 [TBL] [Abstract][Full Text] [Related]
9. Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer. Cortas T; Eisenberg R; Fu P; Kern J; Patrick L; Dowlati A Lung Cancer; 2007 Mar; 55(3):349-55. PubMed ID: 17161498 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Rusch V; Klimstra D; Linkov I; Dmitrovsky E Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337 [TBL] [Abstract][Full Text] [Related]
11. Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling. Conde E; Angulo B; Tang M; Morente M; Torres-Lanzas J; Lopez-Encuentra A; Lopez-Rios F; Sanchez-Cespedes M Clin Cancer Res; 2006 Feb; 12(3 Pt 1):710-7. PubMed ID: 16467080 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor tyrosine kinase inhibitor does not improve paclitaxel effect in an orthotopic mouse model of lung cancer. Onn A; Isobe T; Wu W; Itasaka S; Shintani T; Shibuya K; Kenji Y; O'reilly MS; Fidler IJ; Herbst RS Clin Cancer Res; 2004 Dec; 10(24):8613-9. PubMed ID: 15623645 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components. Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Cox G; Jones JL; O'Byrne KJ Clin Cancer Res; 2000 Jun; 6(6):2349-55. PubMed ID: 10873086 [TBL] [Abstract][Full Text] [Related]
15. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630 [TBL] [Abstract][Full Text] [Related]
16. ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers. Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y J Surg Res; 2008 May; 146(1):43-8. PubMed ID: 17631905 [TBL] [Abstract][Full Text] [Related]
17. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. Johnson FM; Saigal B; Donato NJ J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238 [TBL] [Abstract][Full Text] [Related]
18. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485 [TBL] [Abstract][Full Text] [Related]
19. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer. Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors. Srivastava A; Alexander J; Lomakin I; Dayal Y Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]